ID   RRBL1
AC   CVCL_A7NK
SY   Rituximab-Resistant B-cell Lymphoma 1
DR   Wikidata; Q107116776
RX   PubMed=17675267;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=17675267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=17675267; DOI=10.1532/IJH97.07028;
RA   Tomita A., Hiraga J., Kiyoi H., Ninomiya M., Sugimoto T., Ito M.,
RA   Kinoshita T., Naoe T.;
RT   "Epigenetic regulation of CD20 protein expression in a novel B-cell
RT   lymphoma cell line, RRBL1, established from a patient treated
RT   repeatedly with rituximab-containing chemotherapy.";
RL   Int. J. Hematol. 86:49-57(2007).
//